Cited by 58Diabetes Management and ResearchNon-Invasive Vital Sign MonitoringMobile Health and mHealth Applications

Overview of Artificial Intelligence–Driven Wearable Devices for Diabetes: Scoping Review

Open access
Ahmed, Arfan, Aziz, Sarah, Abd-alrazaq, Alaa, Farooq, Faisal, Sheikh, Javaid·2022·Journal of Medical Internet Research

Abstract

Background: Prevalence of diabetes has steadily increased over the last few decades with 1.5 million deaths reported in 2012 alone. Traditionally, analyzing patients with diabetes has remained a largely invasive approach. Wearable devices (WDs) make use of sensors historically reserved for hospital settings. WDs coupled with artificial intelligence (AI) algorithms show promise to help understand and conclude meaningful information from the gathered data and provide advanced and clinically meaningful analytics. Objective: This review aimed to provide an overview of AI-driven WD features for diabetes and their use in monitoring diabetes-related parameters. Methods: We searched 7 of the most popular bibliographic databases using 3 groups of search terms related to diabetes, WDs, and AI. A 2-stage process was followed for study selection: reading abstracts and titles followed by full-text screening. Two reviewers independently performed study selection and data extraction, and disagreements were resolved by consensus. A narrative approach was used to synthesize the data. Results: From an initial 3872 studies, we report the features from 37 studies post filtering according to our predefined inclusion criteria. Most of the studies targeted type 1 diabetes, type 2 diabetes, or both (21/37, 57%). Many studies (15/37, 41%) reported blood glucose as their main measurement. More than half of the studies (21/37, 57%) had the aim of estimation and prediction of glucose or glucose level monitoring. Over half of the reviewed studies looked at wrist-worn devices. Only 41% of the study devices were commercially available. We observed the use of multiple sensors with photoplethysmography sensors being most prevalent in 32% (12/37) of studies. Studies reported and compared >1 machine learning (ML) model with high levels of accuracy. Support vector machine was the most reported (13/37, 35%), followed by random forest (12/37, 32%). Conclusions: This review is the most extensive work, to date, summarizing WDs that use ML for people with diabetes, and provides research direction to those wanting to further contribute to this emerging field. Given the advancements in WD technologies replacing the need for invasive hospital setting devices, we see great advancement potential in this domain. Further work is needed to validate the ML approaches on clinical data from WDs and provide meaningful analytics that could serve as data gathering, monitoring, prediction, classification, and recommendation devices in the context of diabetes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2196/36010

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Wearable devices and mobile applications powered by AI have become essential tools for real-time diabetes management.

    “Wearable devices and mobile applications powered by AI have become essential tools for real-time diabetes management (37).”

    From Generative artificial intelligence in predictive analysis of diabetes and its complications: a narrative review (2025) · cites this paper as [37]

    The Introduction says apps can deliver diabetes monitoring data and that AI can analyze data collected continuously by wearables. But it describes noninvasive wearables as being in their infancy, while the Discussion says many wearable studies lack machine learning; it does not establish that AI-powered wearables and apps have become essential tools for real-time diabetes management. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [42]Non-invasive analytics based smart system for diabetes monitoring Internet of Things (IoT) Technologies for HealthCare 2018 Cham Springer
  2. [57]Comparison of noninvasive blood glucose estimation using various regression models Advances in Signal Processing and Intelligent Recognition Systems 2020 Singapore Springer
  3. [60]Schwartz FL Marling CR Bunescu RC The promise and perils of wearable physiological sensors for diabetes management J Diabetes Sci Technol 2018 05 15 12 3 587 91 10.1177/1932296818763228 29542348 29542348 PMC6154251 · DOI

Cited by

Sorted by citations

Authors
Ahmed, A., Aziz, S., Abd-alrazaq, A., Farooq, F., & Sheikh, J.
Affiliations
Weill Cornell Medical College in Qatar (QA)
Corresponding author
Ahmed, Arfan
Venue
Journal of Medical Internet Research
Published
2022-08-09
Volume
24
Issue
8
Pages
e36010
ISSN
1438-8871 (ISSN-L)
OpenAlex
W4290777035
Cited by
57
References
54
Citations by year
2026: 14 · 2025: 16 · 2024: 16 · 2023: 9 · 2022: 2
FWCI
1.53
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Journal of Medical Internet Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
  • Weill Cornell Medical College
  • Weill Cornell Medicine - Qatar
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Physical Sciences › Engineering › Biomedical Engineering › Non-Invasive Vital Sign Monitoring
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
Keywords
wearable devices, diabetes mellitus, artificial intelligence, machine learning, blood glucose monitoring, glucose prediction, type 1 diabetes, type 2 diabetes, photoplethysmography, wrist-worn sensors, support vector machine, random forest, non-invasive monitoring
MeSH terms
Wearable Electronic Devices, Artificial Intelligence, Blood Glucose, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review